Timothy Elisha Sweeney MD
Improving ED outcomes in acute infections @ Inflammatix
Join to View Full Profile
540 Oakmead PkwySunnyvale, CA 94085
Phone+1 650-443-3030
Dr. Sweeney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Timothy Sweeney is based in Burlingame, CA, and specializes in the field categorized as Other MD/DO. He completed his medical education at Duke University School of Medicine in 2011, followed by a residency in surgery and a post-doctoral fellowship at Stanford Health Care. Since 2016, he has been serving as the CEO of Inflammatix. Dr. Sweeney has authored several publications, notably in journals such as Nature Medicine and JAMA Network Open, focusing on topics like sepsis, critical illness, and gene-expression-based diagnostics. Additionally, he has been involved in multiple clinical trials related to sepsis diagnosis and prognosis.
Clinical Expertise
- Sepsis, Critical care medicine, General surgery, Acute care surgery
Education & Training
Stanford Health CarePost-Doctoral Fellowship, 2013 - 2015
Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 2011 - 2015
Duke University School of MedicineClass of 2011
Work Experience
InflammatixCeo · May 2016 - Current
Certifications & Licensure
CA State Medical License 2012 - 2021
Awards, Honors, & Recognition
- FDA Breakthrough Device: TriVerity US FDA, 2023
Clinical Trials
- Longitudinal Gene Expression Profiling in Adults After Traumatic Injury Start of enrollment: 2016 Jan 01
- Collection of Clinical Specimens From Volunteers for Assay Development Start of enrollment: 2018 Apr 01
- HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study Start of enrollment: 2018 Jul 23
- Join now to see all
Publications & Presentations
PubMed
- Early sepsis recognition: a pilot study using a rapid high-multiplex host-response mRNA diagnostic test.Jingyi Lu, Michèle A Ter Voert, Mehtap Ünal, Natalie N Whitfield, Oliver Liesenfeld
Intensive Care Medicine Experimental. 2025-02-21 - 1 citationsInternational multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium.Andrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, Yehudit Hasin-Brumshtein, Manoj V Maddali
Biorxiv. 2024-11-15 - Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes.Mihir R Atreya, Min Huang, Andrew R Moore, Hong Zheng, Yehudit Hasin-Brumshtein
Critical Care. 2024-07-17
Press Mentions
Transcriptomic Similarities and Differences in Host Response Between SARS-CoV-2 and Other Viral InfectionsDecember 16th, 2020
Can an Antibiotic Help You? Quick Test Might Someday TellJuly 6th, 2016
Cheap Blood Test Can Discriminate Between Bacterial, Viral InfectionsJuly 6th, 2016- Join now to see all
Professional Memberships
- Member
Industry Relationships
- CEO, Inflammatix
External Links
- Inflammatixhttp://www.inflammatix.com
- Host Response MedEdhttp://www.hostresponsedx.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
